ABO exam phase-in application ends April 30

Article

Interested in becoming ABO certified? Qualifications will change at the end of the month.

The American Board of Optometry (ABO) reminds optometrists that as of April 30, qualifying for the ABO exam under the rules of the 3-year phase-in period expires.

ODs can still become board certified after the phase-in period ends. However, effective May 1, Experience in Active Clinical Practice and Fellowship in the College of Optometrists in Vision Development will no longer be accepted as part of the qualification. Requirements for Category 1 and 2 Education will remain unchanged.

To qualify under the rules of the phase-in period, candidates must complete the following:

•    Apply to become an active candidate no later than April 30.

•    Submit their post-graduate requirements for verification by the ABO no later than June 30.

•    Take the ABO Board Certification Examination no later than January 2014, date of the last exam using phase-in rules.

For more information, visit the ABO Web site at www.americanboardofoptometry.org or e-mail info@abopt.org.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.